meglitinide has been researched along with metformin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Slagle, M | 1 |
| Kuritzky, L; Quillen, DM | 1 |
| Clemens, A; Riemann, JF; Siegel, EG | 1 |
| Black, C; Donnelly, P; McIntyre, L; Royle, PL; Shepherd, JP; Thomas, S | 1 |
| Annemans, L; De Bolle, L; Giri, M; Mehuys, E; Remon, JP; Van Bortel, L; Van Tongelen, I | 1 |
| Malesker, MA | 1 |
| Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
| Dorkhan, M; Frid, A; Groop, L | 1 |
| Hamdy, O; Mitri, J | 1 |
| Möhlig, M; Otto, B; Pfeiffer, AF; Pivovarova, O; Rudovich, N; Spranger, J; Weickert, MO | 1 |
| Cammarota, S; Citarella, A; D'Ettorre, A; De Berardis, G; Germinario, CA; Graziano, G; Lepore, V; Lucisano, G; Menditto, E; Nicolosi, A; Nicolucci, A; Pellegrini, F; Vitullo, F | 1 |
| Backman, JT; Neuvonen, PJ; Niemi, M; Tornio, A | 1 |
| Berlin, JA; Demissie, K; Marcella, SW; Qiu, H; Rhoads, GG | 1 |
| Kopecky, C | 1 |
| Grant, JS; Graven, LJ | 1 |
| Hemmingsen, B; Metzendorf, MI; Richter, B; Sonne, DP | 1 |
| Aronow, WS; Horblitt, A; Jolly, G; Sanaani, A; Yandrapalli, S | 1 |
| Adler, S; Tong, L | 1 |
| Danilova, MM; Glotov, AS; Mikhailova, AA; Nasykhova, YA; Tonyan, ZN | 1 |
| Chen, X; Chen, Y; He, S; Li, G; Qian, X; Shen, X; Xu, X; Zhang, B | 1 |
14 review(s) available for meglitinide and metformin
| Article | Year |
|---|---|
Diabetes mellitus. Medication update.
Topics: alpha-Glucosidases; Benzamides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Type 2 diabetes management: a comprehensive clinical review of oral medications.
Topics: Benzamides; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
[Optimized diabetes therapy in type 2 diabetics].
Topics: Adolescent; Adult; Benzamides; Blood Glucose; Body Mass Index; Child; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Therapy, Combination; Evidence-Based Medicine; Female; Germany; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Patient Education as Topic; Practice Guidelines as Topic; Pregnancy; Respiratory Therapy; Risk Factors; Sulfonylurea Compounds; Time Factors; Weight Loss | 2003 |
Meglitinide analogues for type 2 diabetes mellitus.
Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic | 2007 |
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Topics: Administration, Oral; Aged; Benzamides; Cardiovascular Diseases; Comorbidity; Contraindications; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Diabetes medications and body weight.
Topics: Abdominal Fat; Benzamides; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exenatide; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Peptides; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones; Venoms; Weight Gain; Weight Loss | 2009 |
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.
Topics: Administration, Oral; Aryl Hydrocarbon Hydroxylases; Benzamides; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2012 |
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Progressing From Metformin to Sulfonylureas or Meglitinides.
Topics: Age Factors; Benzamides; Diabetes Mellitus, Type 2; Glycemic Index; Humans; Hypoglycemic Agents; Metformin; Occupational Health; Occupational Health Nursing; Sulfonylurea Compounds | 2016 |
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Topics: Adult; Benzamides; Blood Glucose; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Metformin; Middle Aged; Nateglinide; Phenylalanine; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 2016 |
Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Topics: Benzamides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones | 2017 |
Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
Topics: Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Patient Care Planning; Physicians, Primary Care; Primary Health Care; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones | 2018 |
Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.
Topics: Benzamides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Metformin; Pharmacogenetics; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds | 2020 |
2 trial(s) available for meglitinide and metformin
| Article | Year |
|---|---|
Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes: what to add--insulin glargine or pioglitazone?
Topics: Adiponectin; Adult; Aged; Benzamides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Heart Function Tests; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin Resistance; Insulin, Long-Acting; Metformin; Middle Aged; Pioglitazone; Proinsulin; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Young Adult | 2008 |
Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus.
Topics: Adult; Aged; Benzamides; Blood Glucose; Body Mass Index; C-Peptide; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Eating; Feeding Behavior; Ghrelin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Piperidines; Reference Values; Single-Blind Method | 2010 |
5 other study(ies) available for meglitinide and metformin
| Article | Year |
|---|---|
Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
Topics: Administration, Oral; Benzamides; Diabetes Mellitus, Type 2; Drug Combinations; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2005 |
Medication use and disease management of type 2 diabetes in Belgium.
Topics: Belgium; Benzamides; Blood Glucose Self-Monitoring; Community Pharmacy Services; Counseling; Diabetes Mellitus, Type 2; Disease Management; Drug Utilization Review; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Education as Topic; Pharmacists; Professional Role; Retrospective Studies; Sulfonylurea Compounds; Surveys and Questionnaires; Treatment Outcome | 2008 |
The burden of hospitalization related to diabetes mellitus: a population-based study.
Topics: Adolescent; Adult; Aged; Benzamides; Cost of Illness; Diabetes Mellitus; Female; Hospitalization; Humans; Hypoglycemic Agents; Insulin; Italy; Male; Metformin; Middle Aged; Odds Ratio; Prevalence; Thiazolidinediones; Treatment Outcome; Young Adult | 2012 |
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Breast Neoplasms; Cohort Studies; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones; United Kingdom | 2013 |
Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
Topics: Aged; Benzamides; Carbamates; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycoside Hydrolase Inhibitors; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Mortality; Nateglinide; Piperidines; Proportional Hazards Models; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones | 2021 |